<DOC>
	<DOCNO>NCT02104167</DOCNO>
	<brief_summary>The purpose combine retrospective prospective clinical study examine safety efficacy ROI-C® anterior cervical interbody fusion device VerteBRIDGE® plat treat single level degenerative disc disease C2 T1 short term , focus fusion rate .</brief_summary>
	<brief_title>Retrospective/Prospective Data Collection LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Subject must degenerative disc disease ( DDD ) cervical spine accompany radicular symptom one level C2 T1 . The subject ROIC device one level . Autograft must use ROIC device . Subject minimum 6 ( six ) week nonoperative treatment prior surgery . Subject must least 21 year age time surgery No BMP use interbody cage Subject prisoner time surgery Subject pregnant time surgery Subject active infection sepsis time surgery</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>DDD</keyword>
	<keyword>degenerative disc disease</keyword>
	<keyword>cervical spine</keyword>
	<keyword>fusion rate</keyword>
</DOC>